Log in

Oklahoma ACC 2020 Annual Scientific Meeting

Date & Location

Saturday, August 29, 2020, 7:45 AM - 1:00 PM

Target Audience

Specialties - Cardiology, Cardiovascular Diseases

Professions - Physician, Nurse, Clinical Nurse Specialist (CNS), Nurse Practitioner (NP), Pharmacist, Physician Assistant (PA)



This annual one-day meeting is an exciting program that will highlight world-class faculty discussing up-to-date information about drugs and technologies that are indicated in a variety of common cardiovascular diseases. The content will be oriented toward the entire cardiac

care team. The educational objectives of the session will address the skills required of cardiovascular professionals for providing evidence based care to patients with cardiovascular disease. The intimate format of this meeting will allow the audience to interact with invited speakers, network with colleagues from across the state and meet the cardiology fellows-in-training within the state.


Upon completion of this activity, participants will improve their competence and performance by being able to:

  1. Describe the imaging protocols for Tc-99m PYP imaging.
  2. Discuss the strengths and weaknesses of the various imaging modalities for cardiac amyloidosis.
  3. Explain how to assess cardiac deformation with echo as a measure to be used beyond the global LVEF.
  4. Apply Global Longitudinal Strain findings in a clinically meaningful manner in patients with AS and MR.
  5. Discuss contemporary understanding of difficult clinical scenarios such as low flow low gradient or asymptomatic severe AS.
  6. Review evidence base supporting current recommendations for DAPT after PCI.
  7. Define the high bleeding risk phenotype and clinical trials examining short durations of DAPT in these patients.
  8. Summarize key trials examining Aspirin withdrawal after PCI.
  9. Examine existing approaches for use of triple therapy after PCI.
  10. Identify the most recent recommendations from evidence-based guidelines for the treatment of venous thromboembolism.
  11. Select the appropriate therapy for a patient with VTE.
  12. Apply the recent evidence for the prevention of VTE in hospitalized medical patients at risk for VTE.
  13. Evaluate the evolving perspectives within cardiology community and leadership on MOC through CME and longitudinal assessment.
  14. Assimilate practical tips for the management of complex cardiac patients with problems likely to be encountered in cardiology practice.


  • $25 ACC Members
  • $95 Non ACC Members
  • $25 ACC CCA Members
  • $0 Fellow in Training

Course fee includes CME credits.

Cancellations must be received in writing by August 14, 2020 in order to receive a full refund.

No refunds will be issued after August 14, 2020.


The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 4.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


2650 S. Hanley Rd., Ste. 100
St. Louis, MO  63141

Call or Fax Us

Office: +1 (314) 416-2240
Fax: 314-845-1891

Powered by Wild Apricot Membership Software